This little-known oncology stock could rise more than 70%, says Citi

Olema Oncology could be a leading player in developing therapies for women's cancer, particularly breast cancer, according to Citi Research.…

Syphilis is on the rise in the US.

Syphilis, once nearly eliminated in the United States, continues to reemerge, reaching the highest rate of new infections recorded since…

Pfizer (PFE) 2023 Fourth Quarter Earnings Report

Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit as the company's declining Covid business performed better than expected. The…